Visit Taconic Biosciences at the American Association of Cancer Research Annual Meeting (AACR) 2023

Humanized immune system mice are critical preclinical models to evaluate new immuno-oncology therapeutics across a range of modalities, including cancer vaccines, cell therapies, multi-specific cell engagers and more! Understanding the most appropriate model for your experiment starts from an understanding of your human cell type(s) of interest. Our scientists can discuss presence and function of human immune cells across the range of available models, balancing donor effects and study window limits, to help maximize your experimental success with these powerful models.   

Working with an antibody-based therapy?  Stop by booth #2854 to learn more about the FcResolv™ NOG Portfolio, the first and only super immunodeficient mouse models with knockout of murine Fc gamma receptors to improve accuracy of studies involving antibody-based drugs. 

Designing an epitope-based cancer vaccine?  Taconic’s exclusive portfolio of transgenic HLA mice covers class I and II HLAs.  The expanded portfolio is available on the C57BL/6 strain background to facilitate syngeneic tumor studies. 

Complete the form to schedule a scientific consultation with one of our PhD field application scientists.